Safety Signals, Dosing Errors, and FDA Adverse Event Reports The FDA received reports of serious adverse events, including hospitalizations, linked to dosing errors with compounded injectable products such as semaglutide and tirzepatide
Repeat-dose toxicology studies were conducted in rats and dogs, up to 13-weeks in duration, and clinical pathology endpoints including thyroid hormones were assessed at 2-, 6-, and 13-weeks, as well as following 2- to 4-weeks of recovery
It is recommended to drink it fresh as nutrients can decline over time
Manufacturing is simpler, and there are fewer drug-drug interaction concerns because there is only one drug
Read on to find out if this includes you